1.5797
price up icon0.52%   0.0097
 
loading
전일 마감가:
$1.57
열려 있는:
$1.63
하루 거래량:
217.70K
Relative Volume:
0.38
시가총액:
$43.20M
수익:
$80.97M
순이익/손실:
$-78.31M
주가수익비율:
-0.1064
EPS:
-14.85
순현금흐름:
$-129.56M
1주 성능:
+0.52%
1개월 성능:
-11.34%
6개월 성능:
-20.29%
1년 성능:
-28.26%
1일 변동 폭
Value
$1.55
$1.6399
1주일 범위
Value
$1.41
$1.6399
52주 변동 폭
Value
$1.355
$4.43

Fortress Biotech Inc Stock (FBIO) Company Profile

Name
명칭
Fortress Biotech Inc
Name
전화
781-652-4500
Name
주소
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Name
직원
186
Name
트위터
@fortressbio
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
FBIO's Discussions on Twitter

FBIO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
FBIO 1.575 43.20M 80.97M -78.31M -129.56M -14.85
VRTX 450.34 115.43B 10.63B -479.80M -1.35B 13.33
REGN 746.04 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 591.88 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 245.61 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.38 24.89B 3.30B -501.07M 1.03B 11.54

Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-03-15 재개 ROTH MKM Buy
2022-08-04 개시 Ladenburg Thalmann Buy
2020-10-02 개시 The Benchmark Company Buy
2019-12-18 개시 B. Riley FBR Buy
2018-02-28 개시 B. Riley FBR, Inc. Buy
2017-07-11 개시 Rodman & Renshaw Buy
2017-03-22 개시 JMP Securities Mkt Outperform
2016-10-03 개시 ROTH Capital Buy
모두보기

Fortress Biotech Inc 주식(FBIO)의 최신 뉴스

pulisher
Nov 19, 2024

Fortress Biotech price target raised to $15 from $13 at Roth MKM - TipRanks

Nov 19, 2024
pulisher
Nov 18, 2024

Fortress Biotech price target lowered to $4 from $5 at Alliance Global Partners - TipRanks

Nov 18, 2024
pulisher
Nov 18, 2024

Fortress Biotech price target raised to $26 from $24 at H.C. Wainwright - TipRanks

Nov 18, 2024
pulisher
Nov 18, 2024

Fortress Biotech (FRA:CNB1) Total Inventories : €9.00 Mil (As of Jun. 2024) - GuruFocus.com

Nov 18, 2024
pulisher
Nov 17, 2024

Fortress Biotech Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 17, 2024
pulisher
Nov 15, 2024

Fortress Biotech: Q3 Earnings Snapshot - mySA

Nov 15, 2024
pulisher
Nov 15, 2024

Fortress Biotech Inc. (FBIOP) Quarterly 10-Q Report - Quartz

Nov 15, 2024
pulisher
Nov 14, 2024

Fortress Biotech’s Q3 2024 Earnings and FDA Milestone - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

Fortress Biotech Q3 2024 Earnings: EPS Loss of $0.76 Beats Estimate, Revenue of $14.63M Misses Expectations - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Fortress Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024
pulisher
Nov 14, 2024

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

Avenue Therapeutics Reports $3.1M Q3 Loss, Advances Key Clinical Trials Pipeline | ATXI Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 12, 2024

Mustang Bio gets extension for Nasdaq compliance By Investing.com - Investing.com South Africa

Nov 12, 2024
pulisher
Nov 12, 2024

Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Checkpoint Therapeutics Sets FDA Review Date, Secures $9.2M Funding Boost Amid Q3 Loss | FBIO Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Journey Medical's Mixed Q3: FDA Win for Rosacea Drug Despite Revenue Dip | FBIO Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Mustang Bio gets extension for Nasdaq compliance - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

Mustang Bio Receives Positive Listing Determination from Nasdaq - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Mustang Bio Secures Critical Nasdaq Extension, Faces January 2025 Deadline for $1 Compliance | MBIO Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Where are the Opportunities in (FBIOP) - Stock Traders Daily

Nov 12, 2024
pulisher
Nov 07, 2024

Mustang Bio gains FDA Orphan Drug Status for glioma treatment - Investing.com India

Nov 07, 2024
pulisher
Nov 07, 2024

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

Mustang Bio gains FDA Orphan Drug Status for glioma treatment By Investing.com - Investing.com UK

Nov 07, 2024
pulisher
Nov 01, 2024

How To Trade (FBIOP) - Stock Traders Daily

Nov 01, 2024
pulisher
Oct 31, 2024

Fortress Biotech Insiders Placed Bullish Bets Worth US$4.49m - Yahoo Finance

Oct 31, 2024
pulisher
Oct 30, 2024

Biotech Stocks Facing FDA Decision In November 2024 - RTTNews

Oct 30, 2024
pulisher
Oct 29, 2024

Fortress Biotech, Inc.'s (NASDAQ:FBIO) Shares Bounce 36% But Its Business Still Trails The Industry - Simply Wall St

Oct 29, 2024
pulisher
Oct 25, 2024

Mustang Bio, Inc. Appoints David Jin as A Member of the Board - Marketscreener.com

Oct 25, 2024
pulisher
Oct 25, 2024

Highbridge Capital Management's Strategic Acquisition of Fortress Biotech Shares - Yahoo Finance

Oct 25, 2024
pulisher
Oct 25, 2024

Highbridge Capital Management's Strategic Acquisition of Fortres - GuruFocus.com

Oct 25, 2024
pulisher
Oct 25, 2024

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference - GlobeNewswire

Oct 25, 2024
pulisher
Oct 25, 2024

Mustang Bio secures $4 million from warrant exercises - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

Mustang Bio secures $4 million from warrant exercises By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds - The Manila Times

Oct 24, 2024
pulisher
Oct 09, 2024

Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit - The Manila Times

Oct 09, 2024
pulisher
Oct 09, 2024

Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit - GlobeNewswire

Oct 09, 2024
pulisher
Oct 07, 2024

Analysts review Fortress Biotech Inc’s rating - Knox Daily

Oct 07, 2024
pulisher
Oct 07, 2024

Was there any good news for Fortress Biotech Inc (FBIO) stock in the last session? - US Post News

Oct 07, 2024
pulisher
Oct 03, 2024

PRESIDENT, CEO & CHAIRMAN ROSENWALD LINDSAY A MD acquire 763,359 shares of Fortress Biotech Inc [FBIO] - Knox Daily

Oct 03, 2024
pulisher
Oct 03, 2024

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewswire

Oct 03, 2024

Fortress Biotech Inc (FBIO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Fortress Biotech Inc 주식 (FBIO) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Jul 11 '24
Buy
7.48
5,000
37,418
127,500
Jin David
Chief Financial Officer
Jul 10 '24
Buy
7.50
500
3,750
500
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Jul 09 '24
Buy
7.39
5,000
36,971
122,500
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Jul 08 '24
Buy
7.35
5,000
36,764
117,500
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Jun 28 '24
Buy
1.64
20,000
32,724
2,893,905
ROSENWALD LINDSAY A MD
President, CEO & Chairman
May 16 '24
Buy
1.76
10,000
17,589
2,873,905
Klein Dov
Director
May 20 '24
Sale
1.89
10,000
18,900
53,400
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Jan 05 '24
Buy
2.38
50,000
118,770
2,863,905
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):